Fulgent Genetics, Inc. (FLGT)
Nasdaq · Services-Medical Laboratories · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement, acquisition or disposition of assets
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-10-26 | Kim Paul | officer | F | 2,748 | 20.22 | $55,565 |
| 2026-10-26 | Xie Jian | officer | F | 4,361 | 20.22 | $88,179 |
| 2026-10-26 | Gao Hanlin | officer | F | 1,645 | 20.22 | $33,262 |
| 2026-09-02 | Gao Hanlin | officer | S | 1,673 | 19.66 | $32,885 |
| 2026-09-02 | Xie Jian | officer | S | 2,127 | 19.66 | $41,809 |
| 2026-09-01 | Kim Paul | officer | F | 2,087 | 19.59 | $40,884 |
| 2026-09-01 | Hsieh Ming | director | F | 4,392 | 19.59 | $86,039 |
| 2026-08-27 | Xie Jian | officer | S | 1,193 | 19.91 | $23,747 |
| 2026-08-27 | Gao Hanlin | officer | S | 939 | 19.91 | $18,691 |
| 2026-08-26 | Hsieh Ming | director | F | 2,949 | 19.81 | $58,420 |
| 2026-08-26 | Kim Paul | officer | F | 1,168 | 19.81 | $23,138 |
| 2026-07-26 | Kim Paul | officer | F | 2,747 | 19.67 | $54,033 |
| 2026-07-26 | Xie Jian | officer | F | 4,361 | 19.67 | $85,781 |
| 2026-07-26 | Gao Hanlin | officer | F | 1,645 | 19.67 | $32,357 |
| 2026-06-02 | Xie Jian | officer | S | 2,146 | 17.89 | $38,392 |
| 2026-06-02 | Gao Hanlin | officer | S | 1,688 | 17.89 | $30,198 |
| 2026-06-02 | Xie Jian | officer | S | 2,146 | 17.89 | $38,382 |
| 2026-06-02 | Gao Hanlin | officer | S | 1,688 | 17.89 | $30,191 |
| 2026-06-01 | Kim Paul | officer | F | 2,087 | 18.09 | $37,754 |
| 2026-06-01 | Hsieh Ming | director | F | 4,392 | 18.09 | $79,451 |
| 2026-06-01 | Kim Paul | officer | F | 2,087 | 18.09 | $37,754 |
| 2026-06-01 | Hsieh Ming | director | F | 4,392 | 18.09 | $79,451 |
| 2026-05-27 | Xie Jian | officer | S | 1,201 | 17.6 | $21,138 |
| 2026-05-27 | Gao Hanlin | officer | S | 945 | 17.6 | $16,632 |
| 2026-05-27 | Xie Jian | officer | S | 1,201 | 17.6 | $21,138 |
| 2026-05-27 | Gao Hanlin | officer | S | 945 | 17.6 | $16,632 |
| 2026-05-26 | Kim Paul | officer | F | 1,168 | 17.67 | $20,639 |
| 2026-05-26 | Hsieh Ming | director | F | 2,949 | 17.67 | $52,109 |
| 2026-05-26 | Kim Paul | officer | F | 1,168 | 17.67 | $20,639 |
| 2026-05-26 | Hsieh Ming | director | F | 2,949 | 17.67 | $52,109 |
| 2026-05-14 | Nohaile Michael | director | A | 5,558 | 0 | $0 |
| 2026-05-14 | Dong Linda | director | A | 11,117 | 0 | $0 |
| 2026-05-14 | GROVES REGINA E | director | A | 11,117 | 0 | $0 |
| 2026-05-14 | Nohaile Michael | director | A | 5,558 | 0 | $0 |
| 2026-05-14 | Dong Linda | director | A | 11,117 | 0 | $0 |
| 2026-05-14 | GROVES REGINA E | director | A | 11,117 | 0 | $0 |
| 2026-04-26 | Gao Hanlin | officer | F | 1,645 | 16.31 | $26,830 |
| 2026-04-26 | Xie Jian | officer | F | 4,361 | 16.31 | $71,128 |
| 2026-04-26 | Kim Paul | officer | F | 2,747 | 16.31 | $44,804 |
| 2026-04-26 | Gao Hanlin | officer | F | 1,645 | 16.31 | $26,830 |
| 2026-04-26 | Xie Jian | officer | F | 4,361 | 16.31 | $71,128 |
| 2026-04-26 | Kim Paul | officer | F | 2,747 | 16.31 | $44,804 |
| 2026-03-01 | Kim Paul | officer | F | 1,133 | 15.33 | $17,369 |
| 2026-03-01 | Xie Jian | officer | F | 8,147 | 15.33 | $124,894 |
| 2026-03-01 | Xie Jian | officer | F | 1,079 | 15.33 | $16,541 |
| 2026-03-01 | Kim Paul | officer | F | 8,347 | 15.33 | $127,960 |
| 2026-03-01 | Gao Hanlin | officer | F | 1,018 | 15.33 | $15,606 |
| 2026-03-01 | Gao Hanlin | officer | F | 6,410 | 15.33 | $98,265 |
| 2026-03-01 | Hsieh Ming | director | F | 17,566 | 15.33 | $269,287 |
| 2026-03-01 | Xie Jian | officer | F | 1,079 | 15.33 | $16,541 |
Federal contracts
24-month federal obligations: $6,574
- 2026-09-21 $6,574 · Department of Veterans Affairs · GERMLINE PGX MOLECULAR TESTING
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.